{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T20:06:37Z","timestamp":1767816397856,"version":"3.49.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>\n                    A 77-year-old man with metastatic prostate cancer presented with debilitating bone pain and rising PSA despite anti-androgen therapy.\n                    <jats:sup>68<\/jats:sup>\n                    Ga-PSMA PET\/CT scan revealed widespread PSMA-positive bone metastases with an incidental PSMA-avid renal mass, later confirmed as renal cell carcinoma (RCC). The patient received four cycles of\n                    <jats:sup>177<\/jats:sup>\n                    Lu-PSMA-617, which resulted in complete pain resolution, marked improvement in bone metastases, and PSA reduction; while no change in the renal mass is noted. Despite the beneficial effects of\n                    <jats:sup>177<\/jats:sup>\n                    Lu-PSMA therapy in metastatic prostate cancer, its efficacy in nonprostatic malignancies is under investigation. In this case,\n                    <jats:sup>177<\/jats:sup>\n                    Lu-PSMA-617 did not show remarkable therapeutic efficiency in RCC.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000005964","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T19:00:10Z","timestamp":1749582010000},"page":"e111-e113","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["177Lutetium-PSMA Therapy in a Patient With Concurrent Prostate Cancer and Renal Cell Carcinoma"],"prefix":"10.1097","volume":"51","author":[{"given":"Hajar","family":"Albooyeh","sequence":"first","affiliation":[{"name":"Jam Nuclear Medicine Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Amini","sequence":"additional","affiliation":[{"name":"Khatam PET\/CT Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Arefnia","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Shohada Tajrish Hospital School of Medicine, Shahid Beheshti University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed ali","family":"Aldarraji","sequence":"additional","affiliation":[{"name":"Shahed University, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6011-8236","authenticated-orcid":false,"given":"Ghasemali","family":"Divband","sequence":"additional","affiliation":[{"name":"Jam Nuclear Medicine Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"R1-20260107","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/RLU.0000000000004725","article-title":"Rapid tumor washout of 177 Lu-PSMA radioligand in renal cell carcinoma","volume":"48","author":"Zhang","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R2-20260107","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/RLU.0000000000005583","article-title":"Outcome and renal safety of PSMA-targeted radioligand therapy in mCRPC patients with preexisting impaired renal function","volume":"50","author":"Bastian","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R3-20260107","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1097\/RLU.0000000000005163","article-title":"Complete resolution of locally advanced prostate cancer after molecular endoradiotherapy with 177 Lu-PSMA","volume":"49","author":"Beheshti","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R4-20260107","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/RLU.0000000000005010","article-title":"177 Lu-PSMA-617 therapy in a case of metastatic castration-resistant prostate cancer","volume":"49","author":"Qu","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R5-20260107","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.21873\/anticanres.17037","article-title":"Systematic review of the first 40 cases of 177Lu-PSMA therapy in the treatment of non-prostatic cancer","volume":"44","author":"Golan","year":"2024","journal-title":"Anticancer Res"},{"key":"R6-20260107","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3390\/ph16070995","article-title":"Rationale for prostate-specific-membrane-antigen-targeted radionuclide theranostic applied to metastatic clear cell renal carcinoma","volume":"16","author":"Giraudet","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"R7-20260107","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12885-023-11702-8","article-title":"A multicentric, single arm, open-label, phase I\/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR)","volume":"24","author":"Kryza","year":"2024","journal-title":"BMC Cancer"},{"key":"R8-20260107","doi-asserted-by":"crossref","first-page":"1220586","DOI":"10.3389\/fonc.2023.1220586","article-title":"PSMA-targeted therapy for non-prostate cancers","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol"},{"key":"R9-20260107","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/RLU.0000000000004881","article-title":"68 Ga-LNC-1007 PET\/CT imaging in a patient with renal cell carcinoma compared with 68 Ga-PSMA-11 PET\/CT","volume":"48","author":"Lin","year":"2023","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T19:00:27Z","timestamp":1767812427000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005964","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"2025-01-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}